Bert Regeer, MD
Bert Regeer, MD, has 20 years experience in clinical development strategy, working at some of the largest pharmaceutical companies in the world. Bert uses his expertise in clinical program design, development, and implementation to help clients prepare for FDA interactions and advisory committee meetings. In his role as a senior medical executive at Roche and Bristol Myers Squibb, Bert was instrumental in developing further indications for already-marketed products and increasing market value for those companies. His expertise spans both small molecules and biologics in the areas of oncology, cardiology, infectious diseases, and supportive care. Bert obtained his Medical Degree from Rijksuniversiteit Leiden, The Netherlands.